Key points are not available for this paper at this time.
proof of VEGF-modified macrophages as atheroprotective therapeutic cells by both promotion of vascular repair and inhibition of foam cell formation.
Share your take
Add a clinician perspective alongside expert commentary.
Yan et al. (Wed,) studied this question.